Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Short term Debt (2021 - 2024)

Historic Short term Debt for Biodesix (BDSX) over the last 4 years, with Q2 2024 value amounting to $5.8 million.

  • Biodesix's Short term Debt fell 5990.66% to $5.8 million in Q2 2024 from the same period last year, while for Jun 2024 it was $5.8 million, marking a year-over-year decrease of 5990.66%. This contributed to the annual value of $21.9 million for FY2023, which is 11136.25% up from last year.
  • As of Q2 2024, Biodesix's Short term Debt stood at $5.8 million, which was down 5990.66% from $19.2 million recorded in Q1 2024.
  • Biodesix's Short term Debt's 5-year high stood at $21.9 million during Q4 2023, with a 5-year trough of $5.8 million in Q2 2024.
  • Its 4-year average for Short term Debt is $13.7 million, with a median of $13.1 million in 2021.
  • As far as peak fluctuations go, Biodesix's Short term Debt skyrocketed by 11136.25% in 2023, and later tumbled by 5990.66% in 2024.
  • Biodesix's Short term Debt (Quarter) stood at $17.8 million in 2021, then plummeted by 41.79% to $10.3 million in 2022, then skyrocketed by 111.36% to $21.9 million in 2023, then crashed by 73.29% to $5.8 million in 2024.
  • Its last three reported values are $5.8 million in Q2 2024, $19.2 million for Q1 2024, and $21.9 million during Q4 2023.